The high affinity and specificity of peptides towards biological targets, in addition to their
favorable pharmacological properties, has encouraged the development of many peptide …

This article reviews the development of bifunctional chelates for synthesising 68 Ga
radiopharmaceuticals. It structures the chelates into groups of macrocycles …

Simple Summary Recent medical advancements have strived for a personalized medicine
approach to patients, aimed at optimizing therapy outcomes with minimum toxicity. In this …

Nicotinamide adenine diphosphate (NAD+) is a novel messenger RNA 5′ cap in
Escherichia coli, yeast, mammals, and Arabidopsis. Transcriptome-wide identification of …

Purpose Treatment of late-stage prostate cancer by targeted radiotherapeutics such as 131 I-
MIP-1095 and 177 Lu-PSMA-617 has shown encouraging early results. Lu-177 is preferred …

Simple Summary Prostate and breast cancers are the most common malignancies. Accurate
diagnosis and staging of diseases are important for the prognosis and determination of …

Targeted radionuclide therapy (TRT) is an emerging field and has the potential to become a
major pillar in effective cancer treatment. Several pharmaceuticals are already in routine use …

Most experimental work in the space of bioconjugation chemistry focuses on using new
methods to construct covalent bonds between a cargo molecule and a protein of interest …

Simultaneous targeting of the prostate-specific membrane antigen (PSMA) and gastrin-
releasing peptide receptor (GRPR) could improve the diagnostic accuracy in prostate cancer …

A novel radiofluorinated derivative of bombesin, 18 F-AmBF 3-MJ9, was synthesized and
evaluated for its potential to image prostate cancer by targeting the gastrin releasing peptide …